Shahnawaz, Mohammad <br/><br/>
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.  [electronic resource] 

 -  JAMA neurology  Feb 2017 
 - 163-172 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2016.4547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Biochemical Phenomena<br/>Diagnostic Tests, Routine<br/>Female<br/>Humans<br/>In Vitro Techniques<br/>Lewy Body Disease--cerebrospinal fluid<br/>Male<br/>Multiple System Atrophy--cerebrospinal fluid<br/>Outcome Assessment, Health Care<br/>Parkinson Disease--cerebrospinal fluid<br/>Peptide Fragments--cerebrospinal fluid<br/>Predictive Value of Tests<br/>Protein Aggregation, Pathological--complications<br/>Proteostasis Deficiencies--complications<br/>Retrospective Studies<br/>Sensitivity and Specificity<br/>Severity of Illness Index<br/>alpha-Synuclein--cerebrospinal fluid<br/>tau Proteins--cerebrospinal fluid